Prophylactic and therapeutic agnet for hepatic disorder

Details Prophylactic and therapeutic agnet for hepatic disorder Prophylactic and therapeutic agnet for hepatic disorder

1987-04-30

1989-09-26

Waddell, Frederick E.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

514365, 514562, 514893, 514894, A61K 3133, A61K 31425

Patent

active

048700711

ABSTRACT:
There is provided the use of cysteineglucuronic acid, cysteineglucuronolactone and their salts as a prophylactic and therapeutic agent for hepatic disorder. By administering the compund to a subject in an oral dail does of 1 to 5,000 mg or parenteral daily dose of 1, to 2,000 mg, the elevation of GOT, GPT, LDH, ALP TG or HyP level is suppressed and hepatic disorders can be prevented or cured.

REFERENCES:
Chemical Abstracts, vol. 96 (1982) 143263f.

Affiliated with

Also associated with

Rating

Prophylactic and therapeutic agnet for hepatic disorder does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Prophylactic and therapeutic agnet for hepatic disorder, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prophylactic and therapeutic agnet for hepatic disorder will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-187841